Trusted Resources: Evidence & Education
Scientific literature and patient education texts
A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis
source: Journal of Pain and Symptom Management
year: 2017
authors: Moody K, Abrahams B, Baker R, Santizo R, Manwani D, Carullo V, Eugenio D, Carroll A
summary/abstract:Context:
Sickle cell disease (SCD) vaso-occlusive crisis (VOC) remains an important cause of acute pain in pediatrics and the most common SCD complication. Pain management recommendations in SCD include nonpharmacological interventions. Yoga is one nonpharmacological intervention that has been shown to reduce pain in some populations; however, evidence is lacking in children with VOC.
Objectives:
The primary objective of this study was to compare the effect of yoga vs. an attention control on pain in children with VOC. The secondary objectives were to compare the effect of yoga vs. an attention control on anxiety, lengths of stay, and opioid use in this population.
Methods:
Patients were eligible if they had a diagnosis of SCD, were 5-21 years old, were hospitalized for uncomplicated VOC, and had an admission pain score of >=7. Subjects were stratified based on disease severity and randomized to the yoga or control group.
Results:
Eighty-three percent of patients approached (N = 73) enrolled on study. There were no significant differences in baseline clinical or demographic factors between groups. Compared with the control group, children randomized to yoga had a significantly greater reduction in mean pain score after one yoga session (-0.6 ± 0.96 vs. 0.0 ± 1.37; P = 0.029). There were no significant differences in anxiety, lengths of stay, or opioid use between the two groups.
Conclusion:
This study provides evidence that yoga is an acceptable, feasible, and helpful intervention for hospitalized children with VOC. Future research should further examine yoga for children with SCD pain in the inpatient and outpatient settings.
organization: Indiana University School of Medicine, USA; The Children's Hospital at Montefiore, USADOI: 10.1016/j.jpainsymman.2016.12.351
read more full text
Related Content
-
The Family Perspectivehttp://www.sicklecelltransplantconsortiu...
-
Assessment of executive functions in preschool children with sickle cell anemiaObjectives: Children with sickle cell a...
-
Clinical Transformation in Care for Patients With Sickle Cell Disease at an Urban Academic Medical CenterThis article demonstrates effects on uti...
-
Preclinical Data on Proprietary AKT Inhibitor, ARQ 092, Demonstrating Effectiveness in the Treatment of Sickle Cell ...ArQule, Inc. (Nasdaq: ARQL) today announ...
-
MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-m...Hematopoietic stem cell transplant for s...
-
Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now availab...Medunik USA, a company dedicated to impr...
-
Interfaith Medical CenterThe Department of Pediatrics provides co...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.